VRDN — Viridian Therapeutics, Inc. | XLV Holdings | StockAdder

(VRDN)

Viridian Therapeutics, Inc.

Live chart and latest VRDN stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

VRDN News

Clinical Trials Arena

Viridian Therapeutics’ stock sinks despite positive Phase III TED data

Mar 30, 2026 Barron's

Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.

Apr 6, 2026 qz.com

Viridian Therapeutics (VRDN) Soars 5.6%: Is Further Upside Left in the Stock?

Apr 1, 2026 Yahoo Finance

A Look At Viridian Therapeutics (VRDN) Valuation After A Sharp Multi‑Month Share Price Pullback

Apr 8, 2026 Sahm

Viridian Therapeutics (VRDN) Is Down 18.4% After Strong REVEAL-1 Elegrobart TED Data - What's Changed

Apr 11, 2026 Seeking Alpha

Viridian Therapeutics: Why Elegrobart Phase 3 Results Fail To Challenge Amgen (NASDAQ:VRDN)

Apr 8, 2026 Benzinga

Why Is Viridian Therapeutics Stock Sinking Monday? - Amgen (NASDAQ:AMGN), Viridian Therapeutics (NASDAQ:V

Apr 6, 2026 Stock Titan

Vanguard (VRDN) amendment shows 0 shares; subsidiaries to report separately

Mar 27, 2026 The Motley Fool

Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake

Feb 23, 2026 GuruFocus

Viridian Therapeutics (VRDN) Shares Plummet Over 33%

Mar 30, 2026 The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics (SLNO) and Viridian Therapeutics (VRDN)

Apr 7, 2026 Yahoo Finance

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Nov 5, 2025 GuruFocus

Viridian Therapeutics (VRDN) Experiences Significant Stock Decli

Mar 30, 2026 Seeking Alpha

Viridian Therapeutics Is Ready For An Eventful 2026 (NASDAQ:VRDN)

Nov 6, 2025 Stock Titan

Viridian's thyroid eye disease shot beat placebo in Phase 3 trial